Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Capital Leases (2018 - 2025)

Neurogene's Capital Leases history spans 6 years, with the latest figure at $5000.0 for Q4 2025.

  • For Q4 2025, Capital Leases fell 80.77% year-over-year to $5000.0; the TTM value through Dec 2025 reached $5000.0, down 80.77%, while the annual FY2025 figure was $5000.0, 80.77% down from the prior year.
  • Capital Leases reached $5000.0 in Q4 2025 per NGNE's latest filing, down from $7000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $65000.0 in Q4 2023 to a low of $5000.0 in Q3 2023.
  • Average Capital Leases over 3 years is $24333.3, with a median of $13000.0 recorded in 2025.
  • Peak YoY movement for Capital Leases: surged 783.33% in 2024, then crashed 83.02% in 2025.
  • A 3-year view of Capital Leases shows it stood at $65000.0 in 2023, then plummeted by 60.0% to $26000.0 in 2024, then plummeted by 80.77% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Capital Leases are $5000.0 (Q4 2025), $7000.0 (Q3 2025), and $9000.0 (Q2 2025).